본문 바로가기
KERD
논문KCI 등재

임신 산후 갑상선질환의 진단 치료 권고안

Guidelines for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum

2

조회

0

다운로드

10

인용

0

참고문헌

주제분류의학일반

참고문헌 (262)

  1. Stagnaro-Green A, "Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum", Thyroid, 21(10), pp.1081~1125 (2011)
  2. Abalovich M, "Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 92(8 Suppl), pp.S1~S47 (2007)
  3. Gharib H, "Subclinical hypothyroidism during pregnancy: position statement from the American Association of Clinical Endocrinologists", Endocr Pract, 5, pp.367~368 (1999)
  4. Glinoer D, "The regulation of thyroid function in pregnancy:pathways of endocrine adaptation from physiology to pathology", Endocr Rev, 18(3), pp.404~433 (1997)
  5. van Raaij JM, "Hautvast JG. Energy requirements of pregnancy in The Netherlands", Lancet, 2(8565), pp.953~955 (1987)
  6. Baloch Z, "Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease", Thyroid, 13(1), pp.3~126 (2003)
  7. Negro R, "The thyroid and reproduction", pp.84~95 (2009), Georg Thieme Verlag
  8. Soldin OP, "Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency", Thyroid, 14(12), pp.1084~1090 (2004)
  9. Kahric-Janicic N, "Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy", Thyroid, 17(4), pp.303~311 (2007)
  10. Soldin OP, "Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays", Clin Chim Acta, 349(1-2), pp.181~189 (2004)
  11. Sapin R, "Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy", Clin Lab, 50(9-10), pp.581~584 (2004)
  12. Roti E, "Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns", J Endocrinol Invest, 14(1), pp.1~9 (1991)
  13. Stricker R, "Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals", Eur J Endocrinol, 157(4), pp.509~514 (2007)
  14. Soldin OP, "Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide", Ther Drug Monit, 29(5), pp.553~559 (2007)
  15. Panesar NS, "Reference intervals for thyroid hormones in pregnant Chinese women", Ann Clin Biochem, 38(Pt 4), pp.329~332 (2001)
  16. Marwaha RK, "Establishment of reference range for thyroid hormones in normal pregnant Indian women", BJOG, 115(5), pp.602~606 (2008)
  17. Haddow JE, "The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy", J Med Screen, 11(4), pp.170~174 (2004)
  18. Bocos-Terraz JP, "Thyroid hormones according to gestational age in pregnant Spanish women", BMC Res Notes, 2, pp.237~ (2009)
  19. Dashe JS, "Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges", Obstet Gynecol, 106(4), pp.753~757 (2005)
  20. Walker JA, "Racial comparisons of thyroid function and autoimmunity during pregnancy and the postpartum period", Obstet Gynecol, 106(6), pp.1365~1371 (2005)
  21. Price A, "Comparison of thyroid function in pregnant and nonpregnant Asian and western Caucasian women", Clin Chim Acta, 308(1-2), pp.91~98 (2001)
  22. Benhadi N, "Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy", Clin Endocrinol (Oxf), 66(6), pp.765~770 (2007)
  23. Thienpont LM, "Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 1: thyroidstimulating hormone", Clin Chem, 56(6), pp.902~911 (2010)
  24. Casey BM, "Subclinical hyperthyroidism and pregnancy outcomes", Obstet Gynecol, 107(2 Pt 1), pp.337~341 (2006)
  25. Toft AD, "Werner & Ingbar's the thyroid: a fundamental and clinical text", pp.329~344 (2005), Lippincott, Williams & Wilkins
  26. Anckaert E, "FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC", tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations, 2010, pp.411(17-18), 1348~1353
  27. Lee RH, "Free T4 immunoassays are flawed during pregnancy", Am J Obstet Gynecol, 200(3), pp.260 e1~260 e6 (2009)
  28. Stockigt J, "Assessment of thyroid function: towards an integrated laboratory--clinical approach", Clin Biochem Rev, 24(4), pp.109~122 (2003)
  29. Thienpont LM, "Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine", Clin Chem, 56(6), pp.912~920 (2010)
  30. Allan WC, "Maternal thyroid deficiency and pregnancy complications: implications for population screening", J Med Screen, 7(3), pp.127~130 (2000)
  31. Casey BM, "Subclinical hypothyroidism and pregnancy outcomes", Obstet Gynecol, 105(2), pp.239~245 (2005)
  32. Haddow JE, "Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child", N Engl J Med, 341(8), pp.549~555 (1999)
  33. Abalovich M, "Overt and subclinical hypothyroidism complicating pregnancy", Thyroid, 12(1), pp.63~68 (2002)
  34. Leung AS, "Perinatal outcome in hypothyroid pregnancies", Obstet Gynecol, 81(3), pp.349~353 (1993)
  35. Negro R, "Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy", J Clin Endocrinol Metab, 95(4), pp.1699~1707 (2010)
  36. Negro R, "Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0in the first trimester of pregnancy", J Clin Endocrinol Metab, 95(9), pp.E44~E48 (2010)
  37. Benhadi N, "Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death", Eur J Endocrinol, 160(6), pp.985~991 (2009)
  38. Cleary-Goldman J, "Maternal thyroid hypofunction and pregnancy outcome", Obstet Gynecol, 112(1), pp.85~92 (2008)
  39. Mannisto T, "Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life", J Clin Endocrinol Metab, 95(3), pp.1084~1094 (2010)
  40. Mannisto T, "Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study", J Clin Endocrinol Metab, 94(3), pp.772~779 (2009)
  41. Ashoor G, "Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death", Thyroid, 20(9), pp.989~993 (2010)
  42. Man EB, "Maternal hypothyroxinemia:psychoneurological deficits of progeny", Ann Clin Lab Sci, 21(4), pp.227~239 (1991)
  43. Man EB, "Thyroid function in human pregnancy. 8. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function", Am J Obstet Gynecol, 111(7), pp.905~916 (1971)
  44. Lazarus JH, "Antenatal thyroid screening and childhood cognitive function", N Engl J Med, 366(6), pp.493~501 (2012)
  45. Pop VJ, "Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study", Clin Endocrinol (Oxf), 59(3), pp.282~288 (2003)
  46. Li Y, "Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30months", Clin Endocrinol (Oxf), 72(6), pp.825~829 (2010)
  47. Henrichs J, "Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study", J Clin Endocrinol Metab, 95(9), pp.4227~4234 (2010)
  48. Alexander EK, "Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism", N Engl J Med, 351(3), pp.241~249 (2004)
  49. Mandel SJ, "Increased need for thyroxine during pregnancy in women with primary hypothyroidism", N Engl J Med, 323(2), pp.91~96 (1990)
  50. Kaplan MM, "Monitoring thyroxine treatment during pregnancy", Thyroid, 2(2), pp.147~152 (1992)
  51. Loh JA, "The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism", Thyroid, 19(3), pp.269~275 (2009)
  52. Yassa L, "Thyroid hormone early adjustment in pregnancy (the THERAPY) trial", J Clin Endocrinol Metab, 95(7), pp.3234~3241 (2010)
  53. Abalovich M, "The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism", Thyroid, 20(10), pp.1175~1178 (2010)
  54. Galofre JC, "Increased postpartum thyroxine replacement in Hashimoto's thyroiditis", Thyroid, 20(8), pp.901~908 (2010)
  55. Glinoer D, "Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders", J Clin Endocrinol Metab, 79(1), pp.197~204 (1994)
  56. Negro R, "Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications", J Clin Endocrinol Metab, 91(7), pp.2587~2591 (2006)
  57. Duntas LH, "Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis", Eur J Endocrinol, 148(4), pp.389~393 (2003)
  58. Gartner R, "Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations", J Clin Endocrinol Metab, 87(4), pp.1687~1691 (2002)
  59. Mazokopakis EE, "Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis", Thyroid, 17(7), pp.609~612 (2007)
  60. Karanikas G, "No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis", Thyroid, 18(1), pp.7~12 (2008)
  61. Negro R, "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies", J Clin Endocrinol Metab, 92(4), pp.1263~1268 (2007)
  62. Stranges S, "Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial", Ann Intern Med, 147(4), pp.217~223 (2007)
  63. Braverman LE, "Werner & Ingbar's the thyroid: a fundamental and clinical tex", pp.453~455 (2005), Lippincott, Williams & Wilkins
  64. Krassas GE, "Thyroid function and human reproductive health", Endocr Rev, 31(5), pp.702~755 (2010)
  65. Patil-Sisodia K, "Graves hyperthyroidism and pregnancy: a clinical update", Endocr Pract, 16(1), pp.118~129 (2010)
  66. Goodwin TM, "Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects", Am J Obstet Gynecol, 167(3), pp.648~652 (1992)
  67. Tan JY, "Transient hyperthyroidism of hyperemesis gravidarum", BJOG, 109(6), pp.683~688 (2002)
  68. Niebyl JR, "Clinical practice. Nausea and vomiting in pregnancy", N Engl J Med, 363(16), pp.1544~1550 (2010)
  69. Verberg MF, "Hyperemesis gravidarum, a literature review", Hum Reprod Update, 11(5), pp.527~539 (2005)
  70. Grun JP, "The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies", Clin Endocrinol (Oxf), 46(6), pp.719~725 (1997)
  71. Hershman JM, "Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors", Thyroid, 9(7), pp.653~657 (1999)
  72. Rodien P, "Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin", N Engl J Med, 339(25), pp.1823~1826 (1998)
  73. Glinoer D, "Serum TSH determinations in pregnancy: how, when and why?", Nat Rev Endocrinol, 6(9), pp.526~529 (2010)
  74. Bouillon R, "Thyroid function in patients with hyperemesis gravidarum", Am J Obstet Gynecol, 143(8), pp.922~926 (1982)
  75. Laurberg P, "Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy", Eur J Endocrinol, 160(1), pp.1~8 (2009)
  76. Davis LE, "Thyrotoxicosis complicating pregnancy", Am J Obstet Gynecol, 160(1), pp.63~70 (1989)
  77. Millar LK, "Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism", Obstet Gynecol, 84(6), pp.946~949 (1994)
  78. Papendieck P, "Thyroid disorders of neonates born to mothers with Graves'disease", J Pediatr Endocrinol Metab, 22(6), pp.547~553 (2009)
  79. Phoojaroenchanachai M, "Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight", Clin Endocrinol (Oxf), 54(3), pp.365~370 (2001)
  80. Sheffield JS, "Thyrotoxicosis and heart failure that complicate pregnancy", Am J Obstet Gynecol, 190(1), pp.211~217 (2004)
  81. Azizi F, "The safety and efficacy of antithyroid drugs", Expert Opin Drug Saf, 5(1), pp.107~116 (2006)
  82. Mandel SJ, "The use of antithyroid drugs in pregnancy and lactation", J Clin Endocrinol Metab, 86(6), pp.2354~2359 (2001)
  83. Barbero P, "Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study", Am J Med Genet A, 46A(18), pp.2390~2395 (2008)
  84. Clementi M, "Treatment of hyperthyroidism in pregnancy and birth defects", J Clin Endocrinol Metab, 95(11), pp.E337~E341 (2010)
  85. Clementi M, "Methimazole embryopathy: delineation of the phenotype", Am J Med Genet, 83(1), pp.43~46 (1999)
  86. Bahn RS, "The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration", Thyroid, 19(7), pp.673~674 (2009)
  87. Rivkees SA, "Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use", Int J Pediatr Endocrinol, 2009, pp.132041~ (2009)
  88. Russo MW, "Liver transplantation for acute liver failure from drug induced liver injury in the United States", Liver Transpl, 10(8), pp.1018~1023 (2004)
  89. Rubin PC, "Current concepts: beta-blockers in pregnancy", N Engl J Med, 305(22), pp.1323~1326 (1981)
  90. Sherif IH, "Treatment of hyperthyroidism in pregnancy", Acta Obstet Gynecol Scand, 70(6), pp.461~463 (1991)
  91. Mestman JH, "Hyperthyroidism and pregnancy", Arch Intern Med, 134(3), pp.434~439 (1974)
  92. Glinoer D, "Thyroid hyperfunction during pregnancy", Thyroid, 8(9), pp.859~864 (1998)
  93. Momotani N, "Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status", N Engl J Med, 315(1), pp.24~28 (1986)
  94. Ochoa-Maya MR, "Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism", Thyroid, 9(11), pp.1111~1114 (1999)
  95. Hamburger JI, "Diagnosis and management of Graves' disease in pregnancy", Thyroid, 2(3), pp.219~224 (1992)
  96. Amino N, "Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease", J Clin Endocrinol Metab, 55(1), pp.108~112 (1982)
  97. Laurberg P, "Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association", Eur J Endocrinol, 139(6), pp.584~586 (1998)
  98. Momotani N, "Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy", J Clin Endocrinol Metab, 75(3), pp.738~744 (1992)
  99. Kempers MJ, "Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed", J Clin Endocrinol Metab, 88(12), pp.5851~5857 (2003)
  100. Zwaveling-Soonawala N, "Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease: an effect of maternally derived thyrotrophin receptor antibodies?", Thyroid, 19(6), pp.661~662 (2009)
  101. Gruner C, "Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature", Fetal Diagn Ther, 16(1), pp.47~51 (2001)
  102. Luton D, "Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring", J Clin Endocrinol Metab, 90(11), pp.6093~6098 (2005)
  103. McKenzie JM, "Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies", Thyroid, 2(2), pp.155~159 (1992)
  104. Mitsuda N, "Risk factors for developmental disorders in infants born to women with Graves disease", Obstet Gynecol, 80(3Pt 1), pp.359~364 (1992)
  105. Peleg D, "The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis", Obstet Gynecol, 99(6), pp.1040~1043 (2002)
  106. Zimmerman D, "Fetal and neonatal hyperthyroidism", Thyroid, 9(7), pp.727~733 (1999)
  107. Cohen O, "Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy", Prenat Diagn, 23(9), pp.740~742 (2003)
  108. Polak M, "Fetal and neonatal thyroid function in relation to maternal Graves' disease", Best Pract Res Clin Endocrinol Metab, 18(2), pp.289~302 (2004)
  109. Huel C, "Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter", Ultrasound Obstet Gynecol, 33(4), pp.412~420 (2009)
  110. Porreco RP, "Fetal blood sampling in the management of intrauterine thyrotoxicosis", Obstet Gynecol, 76(3 Pt 2), pp.509~512 (1990)
  111. Daffos F, "Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases", Am J Obstet Gynecol, 153(6), pp.655~660 (1985)
  112. Kilpatrick S, "Umbilical blood sampling in women with thyroid disease in pregnancy: Is it necessary?", Am J Obstet Gynecol, 189(1), pp.1~2 (2003)
  113. Stagnaro-Green A, "Postpartum thyroiditis", Best Pract Res Clin Endocrinol Metab, 18(2), pp.303~316 (2004)
  114. Azizi F, "Treatment of post-partum thyrotoxicosis", J Endocrinol Invest, 29(3), pp.244~247 (2006)
  115. Rotondi M, "The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy", J Clin Endocrinol Metab, 93(10), pp.3985~3988 (2008)
  116. Benhaim Rochester D, "Increased risk of Graves'disease after pregnancy", Thyroid, 15(11), pp.1287~1290 (2005)
  117. Rotondi M, "The post partum period and the onset of Graves' disease: an overestimated risk factor", Eur J Endocrinol, 159(2), pp.161~165 (2008)
  118. Azizi F, "Thyroid function in breast-fed infants whose mothers take high doses of methimazole", J Endocrinol Invest, 25(6), pp.493~496 (2002)
  119. Azizi F, "Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole", J Pediatr Endocrinol Metab, 16(9), pp.1239~1243 (2003)
  120. Wilcox AJ, "Incidence of early loss of pregnancy", N Engl J Med, 319(4), pp.189~194 (1988)
  121. Ellish NJ, "A prospective study of early pregnancy loss", Hum Reprod, 11(2), pp.406~412 (1996)
  122. Toth B, "Recurrent miscarriage: current concepts in diagnosis and treatment", J Reprod Immunol, 85(1), pp.25~32 (2010)
  123. Dudley DJ, "Diabetic-associated stillbirth: incidence, pathophysiology, and prevention", Clin Perinatol, 34(4), pp.611~626 (2007)
  124. De Vivo A, "Thyroid function in women found to have early pregnancy loss", Thyroid, 20(6), pp.633~637 (2010)
  125. Stagnaro-Green A, "Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies", JAMA, 264(11), pp.1422~1425 (1990)
  126. Iijima T, "Effects of autoantibodies on the course of pregnancy and fetal growth", Obstet Gynecol, 90(3), pp.364~369 (1997)
  127. Glinoer D, "Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions", J Clin Endocrinol Metab, 73(2), pp.421~427 (1991)
  128. Sezer K, "Impact of first trimester and postpartum period thyroid autoantibodies on abortus incidence in Turkish pregnant women", Gynecol Endocrinol, 25(6), pp.387~391 (2009)
  129. Prummel MF, "Thyroid autoimmunity and miscarriage", Eur J Endocrinol, 150(6), pp.751~755 (2004)
  130. Imaizumi M, "Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies", Endocrinology, 142(2), pp.823~829 (2001)
  131. Lee YL, "Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model.", Fertil Steril, 91(5Suppl), pp.2104~2109 (2009)
  132. Matalon ST, "The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice", Hum Reprod, 18(5), pp.1094~1099 (2003)
  133. Lee RM, "Recurrent pregnancy loss: summary and clinical recommendations", Semin Reprod Med, 18(4), pp.433~440 (2000)
  134. Baek KH, "Recurrent pregnancy loss: the key potential mechanisms", Trends Mol Med, 13(7), pp.310~317 (2007)
  135. Iravani AT, "Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study", Endocr Pract, 14(4), pp.458~464 (2008)
  136. Kutteh WH, "Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction", Fertil Steril, 71(5), pp.843~848 (1999)
  137. Esplin MS, "Thyroid autoantibodies are not associated with recurrent pregnancy loss", Am J Obstet Gynecol, 179(6 Pt 1), pp.1583~1586 (1998)
  138. Pratt DE, "The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy", Fertil Steril, 60(6), pp.1001~1005 (1993)
  139. Rushworth FH, "Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies", Hum Reprod, 15(7), pp.1637~1639 (2000)
  140. De Carolis C, "Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters", Am J Reprod Immunol, 52(4), pp.263~266 (2004)
  141. Kiprov DD, "The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities", Am J Reprod Immunol, 36(4), pp.228~234 (1996)
  142. Stricker RB, "Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin", Fertil Steril, 73(3), pp.536~540 (2000)
  143. Vaquero E, "Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach", Am J Reprod Immunol, 43(4), pp.204~208 (2000)
  144. Bussen S, "Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure", Hum Reprod, 15(3), pp.545~548 (2000)
  145. Kim CH, "Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome", Am J Reprod Immunol, 40(1), pp.2~8 (1998)
  146. Poppe K, "Assisted reproduction and thyroid autoimmunity: an unfortunate combination?", J Clin Endocrinol Metab, 88(9), pp.4149~4152 (2003)
  147. Kilic S, "The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome", Gynecol Endocrinol, 24(11), pp.649~655 (2008)
  148. Negro R, "Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function", J Endocrinol Invest, 30(1), pp.3~8 (2007)
  149. Toulis KA, "Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis", Eur J Endocrinol, 162(4), pp.643~652 (2010)
  150. Negro R, "Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study", Hum Reprod, 20(6), pp.1529~1533 (2005)
  151. Martin JA, "Are preterm births on the decline in the United States? Recent data from the National Vital Statistics System", NCHS Data Brief, (39), pp.1~8 (2010)
  152. Mathews TJ, "Centers for Disease Control and Prevention, National Center for Health Statistics. Infant mortality statistics from the 2002 period: linked birth", infant death data set, 2004, pp.53(10), 1~29
  153. Petrou S, "The economic consequences of preterm birth during the first 10 years of life", BJOG, 112(Suppl 1), pp.10~15 (2005)
  154. Goldenberg RL, "Epidemiology and causes of preterm birth", Lancet, 371(9606), pp.75~84 (2008)
  155. Luewan S, "Outcomes of pregnancy complicated with hyperthyroidism: a cohort study", Arch Gynecol Obstet, 283(2), pp.243~247 (2011)
  156. Tietgens ST, "Thyroid storm", Med Clin North Am, 79(1), pp.169~184 (1995)
  157. Ghafoor F, "Role of thyroid peroxidase antibodies in the outcome of pregnancy", J Coll Physicians Surg Pak, 16, pp.468~471 (2006)
  158. Haddow JE, "Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery", Obstet Gynecol, 116(1), pp.58~62 (2010)
  159. Struve CW, "Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease", Thyroid, 3(1), pp.7~9 (1993)
  160. Kung AW, "The effect of pregnancy on thyroid nodule formation", J Clin Endocrinol Metab, 87(3), pp.1010~1014 (2002)
  161. Tan GH, "Management of thyroid nodules in pregnancy", Arch Intern Med, 156(20), pp.2317~2320 (1996)
  162. Rosen IB, "Pregnancy and surgical thyroid disease", Surgery, 98(6), pp.1135~1140 (1985)
  163. Marley EF, "Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women", Diagn Cytopathol, 16(2), pp.122~125 (1997)
  164. Smith LH, "Cancer associated with obstetric delivery: results of linkage with the California cancer registry", Am J Obstet Gynecol, 189(4), pp.1128~1135 (2003)
  165. Loh KC, "Familial nonmedullary thyroid carcinoma: a metareview of case series", Thyroid, 7(1), pp.107~113 (1997)
  166. Hegedus L, "Clinical practice. The thyroid nodule", N Engl J Med, 351(17), pp.1764~1771 (2004)
  167. Tucker MA, "Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group", Cancer Res, 51(11), pp.2885~2888 (1991)
  168. Tan GH, "Solitary thyroid nodule. Comparison between palpation and ultrasonography", Arch Intern Med, (22), pp.2418~2423 (1995)
  169. Gharib H, "American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules", Endocr Pract, 12(1), pp.63~102 (2006)
  170. 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안", Endocrinology and Metabolism, 25(4), pp.270~297 (2010), 대한내분비학회
  171. Brander A, "Clinical versus ultrasound examination of the thyroid gland in common clinical practice", J Clin Ultrasound, 20(1), pp.37~42 (1992)
  172. Papini E, "Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87(5), pp.1941~1946 (2002)
  173. Bennedbaek FN, "Management of the solitary thyroid nodule: results of a North American survey", J Clin Endocrinol Metab, 85(7), pp.2493~2498 (2000)
  174. Bennedbaek FN, "Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey", Clin Endocrinol (Oxf), 50(3), pp.357~363 (1999)
  175. Hegedus L, "Management of simple nodular goiter: current status and future perspectives", Endocr Rev, 24(1), pp.102~132 (2003)
  176. Costante G, "Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules", J Clin Endocrinol Metab, 92(2), pp.450~455 (2007)
  177. Atkinson BF, "Fine needle aspiration of the thyroid", Monogr Pathol, (35), pp.166~199 (1993)
  178. Belfiore A, "Fine-needle aspiration biopsy of the thyroid", Endocrinol Metab Clin North Am, 30(2), pp.361~400 (2001)
  179. Choe W, "Thyroid cancer in pregnant women:diagnostic and therapeutic management", Thyroid, 4(4), pp.433~435 (1994)
  180. Goellner JR, "Fine needle aspiration cytology of the thyroid, 1980 to 1986", Acta Cytol, 31(5), pp.587~590 (1987)
  181. Hamburger JI, "Thyroid nodules in pregnancy", Thyroid, 2(2), pp.165~168 (1992)
  182. Oertel YC, "Fine-needle aspiration and the diagnosis of thyroid cancer", Endocrinol Metab Clin North Am, 25(1), pp.69~91 (1996)
  183. Powers C, "Fine needle aspiration biopsy of the head and neck" (1996), Butterworth-Heinemann
  184. Singer PA, "Evaluation and management of the solitary thyroid nodule", Otolaryngol Clin North Am, 29(4), pp.577~591 (1996)
  185. Solomon D, "Fine needle aspiration of the thyroid: an update", Thyroid Today, 16, pp.1~9 (1993)
  186. Zanzonico PB, "Radiation dose to patients and relatives incident to 131I therapy", Thyroid, 7(2), pp.199~204 (1997)
  187. Pauwels EK, "Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders", Eur J Nucl Med, 26(11), pp.1453~1457 (1999)
  188. Berg GE, "Radioiodine treatment of hyperthyroidism in a pregnant women", J Nucl Med, 39(2), pp.357~361 (1998)
  189. Herzon FS, "Coexistent thyroid cancer and pregnancy", Arch Otolaryngol Head Neck Surg, 120(11), pp.1191~1193 (1994)
  190. Monroy-Lozano BE, "Clinical behavior of thyroid papillary cancer in pregnancy: optimal time for its treatment", Ginecol Obstet Mex, 69, pp.359~362 (2001)
  191. Moosa M, "Outcome of differentiated thyroid cancer diagnosed in pregnant women", J Clin Endocrinol Metab, 82(9), pp.2862~2866 (1997)
  192. Nam KH, "Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy", J Surg Oncol, 91(3), pp.199~203 (2005)
  193. Vannucchi G, "Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy", Eur J Endocrinol, 162(1), pp.145~151 (2010)
  194. Vini L, "Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis", Postgrad Med J, 75(881), pp.169~170 (1999)
  195. Yasmeen S, "Thyroid cancer in pregnancy", Int J Gynaecol Obstet, 91(1), pp.15~20 (2005)
  196. Rosen IB, "Pregnancy as a predisposing factor in thyroid neoplasia", Arch Surg, 121(11), pp.1287~1290 (1986)
  197. Chong KM, "Thyroid cancer in pregnancy: a report of 3 cases", J Reprod Med, 52(5), pp.416~418 (2007)
  198. Doherty CM, "Management of thyroid nodules during pregnancy", Laryngoscope, 105(3 Pt 1), pp.251~255 (1995)
  199. Kuy S, "Outcomes following thyroid and parathyroid surgery in pregnant women", Arch Surg, 144(5), pp.399~406 (2009)
  200. Mestman JH, "Thyroid disorders of pregnancy", Endocrinol Metab Clin North Am, 24(1), pp.41~71 (1995)
  201. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
  202. Pacini F, "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium", Eur J Endocrinol, 154(6), pp.787~803 (2006)
  203. Sawka AM, "A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors", Clin Endocrinol (Oxf), 69(3), pp.479~490 (2008)
  204. Garsi JP, "Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies", J Nucl Med, 49(5), pp.845~852 (2008)
  205. Rosvoll RV, "Thyroid carcinoma and pregnancy", Surg Gynecol Obstet, 121(5), pp.1039~1042 (1965)
  206. Hill CS Jr, "The effect of subsequent pregnancy on patients with thyroid carcinoma", Surg Gynecol Obstet, 122(6), pp.1219~1222 (1966)
  207. Leboeuf R, "Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors", Thyroid, 17(6), pp.543~547 (2007)
  208. Rosario PW, "The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease", Thyroid, 17(11), pp.1175~1176 (2007)
  209. Hirsch D, "Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer", Thyroid, 20(10), pp.1179~1185 (2010)
  210. Amino N, "High prevalence of transient post-partum thyrotoxicosis and hypothyroidism", N Engl J Med, 306(14), pp.849~852 (1982)
  211. Stagnaro-Green A, "Clinical review 152: Postpartum thyroiditis", J Clin Endocrinol Metab, 87(9), pp.4042~4047 (2002)
  212. Stagnaro-Green A, "High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy", J Clin Endocrinol Metab, 96(3), pp.652~657 (2011)
  213. Stagnaro-Green A, "A prospective study of lymphocyteinitiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction", J Clin Endocrinol Metab, 74(3), pp.645~653 (1992)
  214. Muller AF, "Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age:recent insights and consequences for antenatal and postnatal care", Endocr Rev, 22(5), pp.605~630 (2001)
  215. Kuijpens JL, "Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease?", J Clin Endocrinol Metab, 83(6), pp.1959~1966 (1998)
  216. Smallridge RC, "Postpartum thyroid disease: a model of immunologic dysfunction", Clin Appl Immunol Rev, 1, pp.89~103 (2000)
  217. Adams H, "The sonographic appearances in postpartum thyroiditis", Clin Radiol, 45(5), pp.311~315 (1992)
  218. Nicholson WK, "Prevalence of postpartum thyroid dysfunction:a quantitative review", Thyroid, 16(6), pp.573~582 (2006)
  219. Alvarez-Marfany M, "Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus", J Clin Endocrinol Metab, 79(1), pp.10~16 (1994)
  220. Gerstein HC, "Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus", Ann Intern Med, 118(6), pp.419~423 (1993)
  221. Elefsiniotis IS, "Post-partum thyroiditis in women with chronic viral hepatitis", J Clin Virol, 41(4), pp.318~319 (2008)
  222. Stagnaro-Green A, "Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery", Lupus, 20(7), pp.690~699 (2011)
  223. Tagami T, "The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease", Thyroid, 17(8), pp.767~772 (2007)
  224. Lazarus JH, "Clinical aspects of recurrent postpartum thyroiditis", Br J Gen Pract, 47(418), pp.305~308 (1997)
  225. Caixas A, "Postpartum thyroiditis in women with hypothyroidism antedating pregnancy?", J Clin Endocrinol Metab, 84(11), pp.4000~4005 (1999)
  226. Walfish PG, "Prevalence and characteristics of post-partum thyroid dysfunction:results of a survey from Toronto, Canada", J Endocrinol Invest, 15(4), pp.265~272 (1992)
  227. Lazarus JH, "Clinical manifestations of postpartum thyroid disease", Thyroid, 9(7), pp.685~689 (1999)
  228. Hayslip CC, "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction", Am J Obstet Gynecol, 159(1), pp.203~209 (1988)
  229. Cox JL, "A controlled study of the onset, duration and prevalence of postnatal depression", Br J Psychiatry, 163, pp.27~31 (1993)
  230. Pop VJ, "Postpartum thyroid dysfunction and depression in an unselected population", N Engl J Med, 324(25), pp.1815~1816 (1991)
  231. Lucas A, "Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?", Clin Endocrinol (Oxf), 55(6), pp.809~814 (2001)
  232. Kuijpens JL, "Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum", Eur J Endocrinol, 145(5), pp.579~584 (2001)
  233. Harris B, "Association between postpartum thyroid dysfunction and thyroid antibodies and depression", BMJ, 305(6846), pp.152~156 (1992)
  234. Pop VJ, "Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression", Acta Endocrinol (Copenh), 129(1), pp.26~30 (1993)
  235. Harris B, "Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women", Br J Psychiatry, 180, pp.327~330 (2002)
  236. Hidaka Y, "Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy", Clin Endocrinol (Oxf), 41(1), pp.15~20 (1994)
  237. Azizi F, "The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis", Eur J Endocrinol, 153(3), pp.367~371 (2005)
  238. Fung HY, "Postpartum thyroid dysfunction in Mid Glamorgan", Br Med J (Clin Res Ed), 296(6617), pp.241~244 (1988)
  239. Vargas MT, "Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction:evidence supporting an autoimmune pathogenesis", J Clin Endocrinol Metab, 67(2), pp.327~333 (1988)
  240. Tachi J, "Long term follow-up and HLA association in patients with postpartum hypothyroidism", J Clin Endocrinol Metab, 66(3), pp.480~484 (1988)
  241. Rasmussen NG, "Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis", Acta Endocrinol (Copenh), 123(4), pp.395~401 (1990)
  242. Stagnaro-Green A, "Approach to the patient with postpartum thyroiditis", J Clin Endocrinol Metab, 97(2), pp.334~342 (2012)
  243. Nohr SB, "Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?", J Clin Endocrinol Metab, 85(9), pp.3191~3198 (2000)
  244. Kampe O, "Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis", J Clin Endocrinol Metab, 70(4), pp.1014~1018 (1990)
  245. Klein RZ, "Prevalence of thyroid deficiency in pregnant women", Clin Endocrinol (Oxf), 35(1), pp.41~46 (1991)
  246. Dosiou C, "Screening pregnant women for autoimmune thyroid disease: a costeffectiveness analysis", Eur J Endocrinol, 158(6), pp.841~851 (2008)
  247. Thung SF, "The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism", Am J Obstet Gynecol, 200(3), pp.267 e1~267 e7 (2009)
  248. Vaidya B, "Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding?", J Clin Endocrinol Metab, 92(1), pp.203~207 (2007)
  249. Horacek J, "Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding", Eur J Endocrinol, 163(4), pp.645~650 (2010)
  250. De Carlucci D Jr, "Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism", Arch Otolaryngol Head Neck Surg, 134(10), pp.1076~1079 (2008)
  251. Canaris GJ, "The Colorado thyroid disease prevalence study", Arch Intern Med, 160(4), pp.526~534 (2000)
  252. Canaris GJ, "Do traditional symptoms of hypothyroidism correlate with biochemical disease?", J Gen Intern Med, 12(9), pp.544~550 (1997)
  253. Jovanovic-Peterson L, "De novo clinical hypothyroidism in pregnancies complicated by type I diabetes, subclinical hypothyroidism, and proteinuria: a new syndrome", Am J Obstet Gynecol, 159(2), pp.442~446 (1988)
  254. Ladenson PW, "Werner & Ingbar's the thyroid: a fundamental and clinical text", pp.857~863 (2005), Lippincott, Williams & Wilkins
  255. Poppe K, "Thyroid dysfunction and autoimmunity in infertile women", Thyroid, 12(11), pp.997~1001 (2002)
  256. Mercado G, "Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma", Cancer, 92(11), pp.2892~2897 (2001)
  257. Rotondi M, "Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?", Eur J Endocrinol, 160(3), pp.403~408 (2009)
  258. Michalaki MA, "Thyroid function in humans with morbid obesity", Thyroid, 16(1), pp.73~78 (2006)
  259. Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)", J Clin Endocrinol Metab, 87(2), pp.489~499 (2002)
  260. Eskes SA, "Amiodarone and thyroid", Best Pract Res Clin Endocrinol Metab, 23(6), pp.735~751 (2009)
  261. Lazarus JH, "Lithium and thyroid", Best Pract Res Clin Endocrinol Metab, 23(6), pp.723~733 (2009)
  262. Vagenakis AG, "Adverse effects of iodides on thyroid function", Med Clin North Am, 59(5), pp.1075~1088 (1975)

이 간행물의 다른 논문 (12건)